
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.390 | 0.390 | 0.000 |
Shares | 99.610 | 99.610 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 16.374 | 19.690 |
Price to Book | 2.819 | 3.813 |
Price to Sales | 2.646 | 2.219 |
Price to Cash Flow | 14.293 | 14.685 |
Dividend Yield | 0.450 | 1.485 |
5 Years Earnings Growth | 15.642 | 10.021 |
Number of long holdings: 34
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UCB | BE0003739530 | 8.35 | 253.90 | +0.28% | |
Swedish Orphan Biovitrum | SE0000872095 | 7.61 | 314.40 | -0.19% | |
Argen-X | NL0010832176 | 6.17 | 679.00 | -0.12% | |
Fresenius SE | DE0005785604 | 4.70 | 46.310 | -0.62% | |
Zealand Pharma | DK0060257814 | 4.24 | 499.60 | -2.08% | |
Merus | NL0011606264 | 3.89 | 94.33 | +0.06% | |
Innovent Biologics | KYG4818G1010 | 3.73 | 100.50 | +2.60% | |
Uniphar | IE00BJ5FQX74 | 3.67 | 3.84 | -1.03% | |
H Lundbeck B | DK0061804770 | 3.36 | 45.66 | -1.13% | |
Torrent Pharma | INE685A01028 | 3.20 | 3,536.90 | +0.31% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Technology Fund R | 9.82B | 26.25 | 29.74 | 20.62 | ||
Global Technology Fund I | 9.82B | 26.67 | 30.38 | 21.16 | ||
Global Technology Fund | 9.82B | 17.39 | 29.43 | 19.08 | ||
IE00BFMFD979 | 3.81B | 7.08 | -5.04 | - | ||
IE00BJ205H20 | 3.81B | 6.77 | -5.27 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review